This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
CSX (CSX) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
CSX (CSX) delivered earnings and revenue surprises of 6.38% and 4.74%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Norfolk Southern (NSC) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Norfolk Southern (NSC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Canadian National (CNI) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
CN (CNI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Are You Looking for a High-Growth Dividend Stock?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Canadian National (CNI) have what it takes? Let's find out.
The Zacks Analyst Blog Highlights Berkshire Hathaway, The Walt Disney, CVS Health, Citigroup and Canadian National Railway
by Zacks Equity Research
Berkshire Hathaway, The Walt Disney, CVS Health, Citigroup and Canadian National Railway are part of Zacks top Analyst Blog.
Top Research Reports for Berkshire Hathaway, Walt Disney & CVS
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway Inc. (BRK.B), The Walt Disney Company (DIS) and CVS Health Corporation (CVS).
Canadian National (CNI) Announces Termination of IBEW-Led Strike
by Zacks Equity Research
Announcement of the termination of IBEW-Led strikes brings a sense of relief for Canadian National Railway Company (CNI).
Why Canadian National (CNI) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Canadian National (CNI) have what it takes? Let's find out.
IBEW-Led Strike Leaves Zero Effect on Canadian National (CNI)
by Zacks Equity Research
Canadian National's (CNI) operational contingency plan allows it to maintain the normalcy of operations despite the current turbulence.
Canadian National (CNI) Gets 72-Hour Strike Notice From IBEW
by Zacks Equity Research
Canadian National (CNI) receives a 72-hour strike notice from the IBEW, mainly on pay and benefit-related issues.
Here's Why You Should Hold Canadian National (CNI) Stock Now
by Zacks Equity Research
Canadian National (CNI) rides on decreased labor expenses and high freight demand. A weak balance sheet is, however, a downside.
Why Canadian National (CNI) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Canadian National (CNI) have what it takes? Let's find out.
Wabtec (WAB) Receives Canadian National's New Software Order
by Zacks Equity Research
Wabtec (WAB) receives Canadian National's order for its newly launched Precision Dispatch System, which is expected to help the latter increase capacity and improve efficiency across its network.
Why Is CN (CNI) Down 9.2% Since Last Earnings Report?
by Zacks Equity Research
CN (CNI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Canadian National (CNI) is a Top Dividend Stock Right Now: Should You Buy?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Canadian National (CNI) have what it takes? Let's find out.
Are You Looking for a High-Growth Dividend Stock? Canadian National (CNI) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Canadian National (CNI) have what it takes? Let's find out.
ALSMY vs. CNI: Which Stock Is the Better Value Option?
by Zacks Equity Research
ALSMY vs. CNI: Which Stock Is the Better Value Option?
What's in the Offing for Genco Shipping (GNK) in Q1 Earnings?
by Zacks Equity Research
High fuel costs are likely to have hurt the bottom-line performance of Genco Shipping (GNK) in Q1.
Canadian Pacific's (CP) Q1 Earnings & Revenues Decline Y/Y
by Zacks Equity Research
Softness in freight revenues hurts Canadian Pacific's (CP) Q1 results.
Canadian National (CNI) Shares Dip 2% on Q1 Earnings Miss
by Zacks Equity Research
Canadian National's (CNI) Q1 results are hurt by supply chain disruptions and severe winter conditions. However, higher freight revenues boost performance.
Canadian National (CNI) Q1 Earnings Lag Estimates
by Zacks Equity Research
CN (CNI) delivered earnings and revenue surprises of -3.70% and 0.99%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Canadian National (CNI) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
CN (CNI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Solid Liquidity Ups Canadian National (CNI) Despite Rising Costs
by Zacks Equity Research
Canadian National (CNI) banks on a strong balance sheet and shareholder-friendly measures. However, escalating expenses are worrisome.
The Zacks Analyst Blog Highlights Alphabet, Abbott Laboratories, The Charles Schwab, Canadian National Railway Company and Air Products and Chemicals
by Zacks Equity Research
Alphabet, Abbott Laboratories, The Charles Schwab, Canadian National Railway Company and Air Products and Chemicals have been included in this Analyst Blog.
Top Research Reports for Alphabet, Abbott, & Charles Schwab
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), Abbott Laboratories (ABT) and The Charles Schwab Corporation (SCHW).